Brain-damaging potential of protein hydrolysates.
D000409:Alanine / Q000008:administration & dosage / Q000009:adverse effects; D000596:Amino Acids / Q000008:administration & dosage / Q000009:adverse effects; D000818:Animals; D001224:Aspartic Acid / Q000008:administration & dosage / Q000009:adverse effects; D001925:Brain Damage, Chronic / Q000139:chemically induced*; D002364:Caseins / Q000008:administration & dosage / Q000009:adverse effects; D005337:Fibrin / Q000008:administration & dosage / Q000009:adverse effects; D005971:Glutamates / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects / Q000473:pathology; D007279:Injections, Subcutaneous; D051379:Mice; D009410:Nerve Degeneration; D010288:Parenteral Nutrition / Q000009:adverse effects; D011492:Protein Hydrolysates / Q000008:administration & dosage / Q000009:adverse effects*; D013451:Sulfonic Acids / Q000008:administration & dosage / Q000009:adverse effects
D000596:Amino Acids; D002364:Caseins; D005971:Glutamates; D011492:Protein Hydrolysates; D013451:Sulfonic Acids; D001224:Aspartic Acid; D005337:Fibrin; D000409:Alanine